SynthesisFrontiers in oncology2026

First-line therapies for unresectable hepatocellular carcinoma: a network meta-analysis of immune checkpoint inhibitors and transarterial therapies based on 35 randomized trials.

Huanghui Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.